WALVAX BIOTECHNOLO financial statements, including revenue, expenses, profit, and loss

The total revenue of 300142 for the last quarter is 595.58 M CNY, and it's 37.25% lower compared to the previous quarter. The net income of Q1 24 is 14.13 M CNY.